“…[1][2][3][4] During the last decades, the construction of steroidal N-heterocycles widely to pay attention since they had great research potential for the treatment of a great deal of diseases, especially anticancer activity, [5] e. g., pyridine, benzimidazole, imidazole, and triazole fused with A-ring or substituted with D-ring in the steroid skeletons. [6][7][8] At present, steroidal derivatives with D-ring fused N-heterocycle, abiraterone and galeterone have been used in the clinic for the treatment of prostate cancers, [6,9,10] while steroidal derivatives with D-ring substituted N-heterocycle, 1,3,5 (10)-estratrien [17,16-c]pyrazole was also a potent inhibitor of 17β-hydroxysteroid dehydrogenases (17β-HSD) with IC 50 values of 530 nM against human breast cancer T47-D cells [11,12] (Figure 1), suggesting the D-ring fused or substituted N-heterocyclic system possibly was a promising structural modification strategy to improve antitumor activity for steroids. Even though numerous steroidal N-heterocycles with pyrazole, isoxazole, pyridine, pyran, pyrrole and pyrimidine rings had been successful synthesized by various synthetic strategies in the literature, [13 -20] the structure-activity relationship (SAR) of the different Nheterocyclic systems located to the D-ring were seldom reported and deserved further study.…”